机译:心脏移植接受者妊娠后的De Novo HLA致敏和抗体介导的排斥反应
Departments of Cardiology and Transplant Medicine, Harefield Hospital, Middlesex, UK;
Departments of Cardiology and Transplant Medicine, Harefield Hospital, Middlesex, UK;
Departments of Cardiology and Transplant Medicine, Harefield Hospital, Middlesex, UK;
Departments of Cardiology and Transplant Medicine, Harefield Hospital, Middlesex, UK;
Departments of Cardiology and Transplant Medicine, Harefield Hospital, Middlesex, UK;
Departments of Cardiology and Transplant Medicine, Harefield Hospital, Middlesex, UK|Faculty of Medicine, Imperial College, London, South Kensington Campus, London, UK;
Antibody-mediated rejection; cardiac allograft rejection; cardiac transplant; HLA antibodies; humoral rejection; pregnancy after transplantation;
机译:心脏移植接受者怀孕后从头开始HLA致敏和抗体介导的排斥反应。
机译:II类HLA EPLET Mispatch是De Novo供体特异性抗体发育和肾移植受体中抗体介导的抑制剂的危险因素
机译:De Novo供体特异性HLA抗体在有和没有抗体介导的排斥反应的肾脏移植受者中的C1q结合活性
机译:治疗难治性抗体在两个移植受者中用硼替佐米介导的抑制剂:对供体特异性抗HLA抗体的影响
机译:在发育抗体介导的排斥之前,在儿科肾移植受者中可检测到具有记忆和抗体分泌表型的循环B细胞
机译:高滴度处的持续性强抗HLA抗体是补体结合并且与心脏移植受者在心脏移植受者中增加的抗体介导的抑制风险增加
机译:由于妊娠后抗HLA-DQ抗体引起的抗体介导的抑制剂在女性肾移植受体中递送